What We Do

Vision

Tanzania free of Tuberculosis and Leprosy - zero deaths, disease and suffering due to tuberculosis and leprosy.

Mission

Provision of high-quality TB and Leprosy interventions with a focus on universal access, equity, gender, and those most at risk through effective and sustainable collaboration with partners and stakeholders at all levels.

Goal

To reduce burden and suffering from Tuberculosis and Leprosy diseases in Tanzania by 2025.

Indicators

1. 50 percent reduction in tuberculosis incidence rate (compared to 2015)
2. 75 percent reduction in the number of tuberculosis deaths (compared to 2015)
3. 50 percent reduction of TB affected families facing catastrophic costs due to TB
4. 0 children (under fifteen years of age) newly diagnosed with Leprosy presenting with Grade 2 Disabilities at diagnosis.

Objectives

The sixth National Strategic Plan for Tuberculosis and Leprosy (2020-2025) has invested in

informed and impactful interventions with ambitious targets. The interventions are organized in nine thematic areas, which are formulated as objectives as follows:

1. To increase TB treatment coverage from 53% in 2018 to 90% by innovatively addressing barriers to access, utilization, and the needs of the key and vulnerable populations for TB care and prevention services,
2. To expand access of quality TB diagnostic services, including the adoption of new technologies by 2025,
3. To maintain proportion of children TB among the notified cases at 15% and increasing the ratio of ages ‘0-4’:5-14 years from 1.3 in 2019 to 1.5 by 2025,
4. To increase RR/MDR-TB cases detected and enrolled for treatment from 54% to 90% of the estimated TB cases among the notified by 2025,
5. To Strengthen the management of co-morbidities including Collaborative TB/HIV, TB/Diabetes,
6. To strengthen TB services to the population of miners and their families by 2025,
7. To reduce leprosy prevalence in all endemic councils by 2025,
8. To ensure the availability of supportive systems and strengthened Program management for the implementation of TB and Leprosy Services by 2025, and
9. To ensure implementation of evidence-based interventions and decision making through institutionalized efficient M&E system and coordination of researches by 2025.